Correlation Between Conduit Pharmaceuticals and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Cue Biopharma, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Cue Biopharma.
Diversification Opportunities for Conduit Pharmaceuticals and Cue Biopharma
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Conduit and Cue is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Cue Biopharma go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and Cue Biopharma
Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 4.02 times more return on investment than Cue Biopharma. However, Conduit Pharmaceuticals is 4.02 times more volatile than Cue Biopharma. It trades about 0.26 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.17 per unit of risk. If you would invest 0.95 in Conduit Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 0.60 from holding Conduit Pharmaceuticals or generate 63.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 54.55% |
| Values | Daily Returns |
Conduit Pharmaceuticals vs. Cue Biopharma
Performance |
| Timeline |
| Conduit Pharmaceuticals |
| Cue Biopharma |
Conduit Pharmaceuticals and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Conduit Pharmaceuticals and Cue Biopharma
The main advantage of trading using opposite Conduit Pharmaceuticals and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Conduit Pharmaceuticals vs. Cue Biopharma | Conduit Pharmaceuticals vs. Tff Pharmaceuticals | Conduit Pharmaceuticals vs. Eliem Therapeutics | Conduit Pharmaceuticals vs. Inhibrx |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |